Tirapazamine-loaded CalliSpheres microspheres enhance synergy between tirapazamine and embolization against liver cancer in an animal model

提拉帕扎明 肿瘤缺氧 肝细胞癌 缺氧(环境) 肝癌 细胞毒性 前药 栓塞 医学 化疗 经导管动脉化疗栓塞 癌症研究 药理学 体外 病理 化学 放射治疗 内科学 外科 生物化学 氧气 有机化学
作者
Qing Li,Yiming Liu,Xiaopeng Guo,Lijie Zhang,Lin Li,Dan Zhao,Xin Zhang,Wei Hong,Chuansheng Zheng,Bin Liang
出处
期刊:Biomedicine & Pharmacotherapy [Elsevier BV]
卷期号:151: 113123-113123 被引量:13
标识
DOI:10.1016/j.biopha.2022.113123
摘要

Tirapazamine (TPZ) is a promising hypoxia-selective cytotoxic agent that may exert synergistic tumor-killing activity with transcatheter arterial embolization (TAE) for liver cancer. To investigated whether TPZ-loaded microspheres enhance the synergy between TPZ and TAE in liver cancer, we prepared TPZ-loaded CalliSpheres microspheres (CSMTPZs) and characterized their properties as a chemoembolization agent in vitro. Tumor hypoxia after TAE was detected in the rabbit VX2 model of liver cancer using a modified Clark-type microelectrode research system. CSMTPZ therapy was performed in the animal model. The plasma and tumor concentrations of TPZ and its metabolites were measured, and the efficacy and safety of CSMTPZ therapy were evaluated and compared with those of the conventional combination of intraarterial TPZ injection and embolization. The results showed that CSMTPZs displayed favorable in vitro properties including drug loading and release and microsphere size, shape, and surface profiles. TAE induced acute tumor hypoxia, but residual tumor cells responded to hypoxia through hypoxia-inducible factor 1α. CSMTPZ therapy improved TPZ delivery into tumor tissue with minimal systemic exposure. Accordingly, CSMTPZ therapy exhibited advantages in terms of hypoxia-selected cytotoxicity, tumor apoptosis and necrosis, animal survival, and safety over the conventional combination of TPZ and TAE. We revealed the improved synergistic anti-tumor effects of CSMTPZ therapy in the rabbit VX2 liver cancer model. Our data support the clinical evaluation of CSMTPZs in the treatment of hepatocellular carcinoma, and CSMTPZ administration might serve as a successful therapeutic strategy for this malignancy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
fasiofafew完成签到,获得积分10
1秒前
li发布了新的文献求助10
1秒前
luyue9406的应助被aaaaa采纳,获得10
2秒前
彭于晏的应助被Lin采纳,获得10
2秒前
Bluria发布了新的文献求助10
2秒前
3秒前
4秒前
外向白凡完成签到,获得积分10
4秒前
5秒前
LZ发布了新的文献求助10
7秒前
杜玉完成签到 ,获得积分10
8秒前
9秒前
研友_VZG7GZ的应助被松尾菌采纳,获得30
9秒前
窦誉发布了新的文献求助10
10秒前
彭于晏的应助被天天采纳,获得10
10秒前
spingstee完成签到,获得积分10
10秒前
风吹麦浪发布了新的文献求助10
10秒前
赘婿的应助被Bluria采纳,获得10
11秒前
11秒前
13秒前
Bake完成签到 ,获得积分0
13秒前
风吹麦浪发布了新的文献求助10
14秒前
核桃发布了新的文献求助30
17秒前
CynthiaLi完成签到,获得积分10
17秒前
Aoooo完成签到,获得积分10
19秒前
pangpang发布了新的文献求助10
19秒前
misong完成签到,获得积分10
19秒前
19秒前
21秒前
21秒前
搞怪的老九的应助被成俊杰采纳,获得10
22秒前
上官若男的应助被uu采纳,获得10
23秒前
yao chen完成签到,获得积分10
23秒前
lalaland发布了新的文献求助30
24秒前
24秒前
hsj完成签到,获得积分10
26秒前
之寻完成签到 ,获得积分10
26秒前
完美世界的应助被hehe_733采纳,获得30
26秒前
lx的应助被Yaya采纳,获得20
27秒前
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8191198
求助须知:如何正确求助?哪些是违规求助? 9578129
关于积分的说明 21856860
捐赠科研通 7790454
什么是DOI,文献DOI怎么找? 3436543
关于科研通互助平台的介绍 2560339
邀请新用户注册赠送积分活动 2483298